共有 1 页
品牌 | 货号 | 包装单位 | 货期 | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
---|---|---|---|---|---|---|---|
罗恩 | R022882-5mg | 5mg | 5~7个工作日 |
AMG-517 AMG-517 |
99% |
|
|
罗恩 | R022882-25mg | 25mg | 5~7个工作日 |
AMG-517 AMG-517 |
99% |
|
|
阿拉丁 | A129715-5mg | 5mg | 现货 |
AMG-517,TRPV1拮抗剂 AMG-517 |
Moligand™, ≥99% |
|
|
阿拉丁 | A129715-25mg | 25mg | 现货 |
AMG-517,TRPV1拮抗剂 AMG-517 |
Moligand™, ≥99% |
|
|
阿拉丁 | A129715-1mg | 1mg | 现货 |
AMG-517,TRPV1拮抗剂 AMG-517 |
Moligand™, ≥99% |
|
|
阿拉丁 | A129715-10mg | 10mg | 现货 |
AMG-517,TRPV1拮抗剂 AMG-517 |
Moligand™, ≥99% |
|
|
阿拉丁 | A129715-50mg | 50mg | 现货 |
AMG-517,TRPV1拮抗剂 AMG-517 |
Moligand™, ≥99% |
|
|
阿拉丁 | A408318-1ml | 1ml | 现货 |
AMG-517 AMG-517 |
Moligand™, 10mM in DMSO |
|
|
凯为 | JZ00FCZE-100mg | 100mg | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
凯为 | JZ00FCZE-250mg | 250mg | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
凯为 | JZ00FCZE-1g | 1g | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
凯为 | JZ00FCZE-10mg | 10mg | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
凯为 | JZ00FCZE-25mg | 25mg | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
凯为 | JZ00FCZE-50mg | 50mg | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... AMG 517 |
98+% |
|
|
毕得 | BD370208-5mg | 5mg | 现货 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(Trifluoromethyl... |
98+% |
|
|
毕得 | BD370208-50mg | 50mg | 现货 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(Trifluoromethyl... |
98+% |
|
|
毕得 | BD370208-10mg | 10mg | 现货 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(Trifluoromethyl... |
98+% |
|
|
毕得 | BD370208-25mg | 25mg | 现货 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(Trifluoromethyl... |
98+% |
|
|
毕得 | BD370208-250mg | 250mg | 现货 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(Trifluoromethyl... |
98+% |
|
|
韶远 | SY341710-0.25g | 0.25g | 现货 |
N-[4-[[6-[4-(三氟甲基)苯基]-4-嘧啶基]... N-[4-[[6-[4-(Trifluoromethyl... |
≥95% |
|
|
百灵威 | JK1214989-25MG | 25MG | 1天 |
AMG 517 AMG 517, 98% |
98% |
|
|
百灵威 | JK1214989-5MG | 5MG | 1天 |
AMG 517 AMG 517, 98% |
98% |
|
|
安耐吉 | B021363-100mg | 100mg | 期货,请咨询 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(trifluoromethyl... |
97% |
|
|
安耐吉 | B021363-1g | 1g | 期货,请咨询 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(trifluoromethyl... |
97% |
|
|
安耐吉 | B021363-250mg | 250mg | 期货,请咨询 |
N-(4-((6-(4-(三氟甲基)苯基)嘧啶-4-基)... N-(4-((6-(4-(trifluoromethyl... |
97% |
|
|
源叶 | S81514-1mg | 1mg | 现货 |
Amg 517 Amg 517 |
99% |
|
|
源叶 | S81514-5mg | 5mg | 现货 |
Amg 517 Amg 517 |
99% |
|
|
源叶 | S81514-10mg | 10mg | 现货 |
Amg 517 Amg 517 |
99% |
|
|
源叶 | S81514-25mg | 25mg | 现货 |
Amg 517 Amg 517 |
99% |
|
|
源叶 | S81514-50mg | 50mg | 现货 |
Amg 517 Amg 517 |
99% |
|
|
源叶 | T94278-1ml | 1ml | 期货,请咨询 |
AMG-517 AMG-517 |
10mM in DMSO |
|
|
Target Mol | T6379-1mg | 1mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-5mg | 5mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-10mg | 10mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-50mg | 50mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-100mg | 100mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-1mL | 1mL | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Target Mol | T6379-25mg | 25mg | 现货 |
化合物 AMG517 AMG 517 |
99.85% |
|
|
Am | A593913-1mg | 1mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
Am | A593913-50mg | 50mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
Am | A593913-10mg | 10mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
Am | A593913-100mg | 100mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
Am | A593913-5mg | 5mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
Am | A593913-25mg | 25mg | 现货 |
AMG 517 AMG 517 |
98+% |
|
|
MCE | HY-10634-100mg | 100mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-50mg | 50mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-25mg | 25mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-10mg | 10mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-10mM*1mL | 10mM*1mL | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-5mg | 5mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|
MCE | HY-10634-1mg | 1mg | 现货 |
AMG 517 AMG 517 |
99.97% |
|
|